Suppr超能文献

术后放疗与单纯手术治疗垂体腺瘤患者的第二肿瘤发生率和死亡率。

The incidence of second tumours and mortality in pituitary adenoma patients treated with postoperative radiotherapy versus surgery alone.

机构信息

Department of Radiation Oncology, University of Eroningen, University Medical Center Groningen, Groningen, The Netherlands.

出版信息

Radiother Oncol. 2012 Jul;104(1):125-30. doi: 10.1016/j.radonc.2012.04.024. Epub 2012 Jun 8.

Abstract

BACKGROUND AND PURPOSE

To assess and compare the incidence of intra- and extracranial tumours and mortality in pituitary adenoma patients treated with postoperative radiotherapy and surgery alone.

PATIENTS AND METHODS

A total of 462 pituitary adenoma patients were treated between 1959 and 2008 at the University Medical Center Groningen in The Netherlands. Postoperative radiotherapy was administered on indication in 236 patients.

RESULTS

The median follow-up time was 14 (range 1-49) years in patients treated with radiotherapy and 6 (range 1-34) years in patients treated with surgery alone. Three radiotherapy patients developed an intracranial tumour compared to one patient treated with surgery alone. The numbers of extracranial tumours per follow-up year were 6.5 (95% CI 2.5-10.5) and 5.1 (95% CI 1.9-8.2) in patients treated with and without a technique with vertex field and central body axis irradiation and 7.1 (CI 95% 2.9-11.2) in surgery alone patients. Forty-five patients treated with radiotherapy died compared to twenty-four patients treated with surgery alone (log-rank test RR 1.26, 95% CI 0.77-2.08, p=0.36).

CONCLUSION

In this study postoperative radiotherapy and a radiotherapy treatment technique with vertex field and central body axis irradiation were not associated with an increased incidence of second tumours and mortality in pituitary adenoma patients.

摘要

背景与目的

评估和比较接受术后放疗和单纯手术治疗的垂体腺瘤患者的颅内和颅外肿瘤发生率和死亡率。

患者与方法

1959 年至 2008 年期间,荷兰格罗宁根大学医学中心共治疗了 462 例垂体腺瘤患者。236 例患者根据病情接受术后放疗。

结果

接受放疗的患者中位随访时间为 14 年(范围 1-49 年),接受单纯手术治疗的患者为 6 年(范围 1-34 年)。3 例放疗患者出现颅内肿瘤,而单纯手术治疗的患者有 1 例。接受和不接受顶野和中央体轴照射技术治疗的患者,每年随访的颅外肿瘤数分别为 6.5(95%CI 2.5-10.5)和 5.1(95%CI 1.9-8.2),而单纯手术治疗的患者为 7.1(95%CI 2.9-11.2)。接受放疗的 45 例患者死亡,而接受单纯手术治疗的 24 例患者死亡(对数秩检验 RR 1.26,95%CI 0.77-2.08,p=0.36)。

结论

在这项研究中,术后放疗和使用顶野和中央体轴照射技术的放疗治疗方法与垂体腺瘤患者的第二肿瘤发生率和死亡率增加无关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验